Bibliographies thématiques / CR13626 / Articles de revues
Pour voir les autres types de publications sur ce sujet consultez le lien suivant : CR13626.

Articles de revues sur le sujet « CR13626 »

Auteur : Grafiati
Publié le 9 mars 2023
Mis à jour le 10 mars 2023

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les 21 meilleurs articles de revues pour votre recherche sur le sujet « CR13626 ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.

1

Galimberti, C., M. Montagna, T. Piepoli, O. Letari, G. Caselli, R. Artusi, M. Colovic, S. Persiani et L. C. Rovati. « P11.24 CR13626, an oral tyrosine kinase inhibitor crossing the blood brain barrier, reduces tumour growth and prolongs survival in a mouse model of glioblastoma ». Neuro-Oncology 21, Supplement_3 (août 2019) : iii47—iii48. http://dx.doi.org/10.1093/neuonc/noz126.170.

Texte intégral
Résumé :
Abstract BACKGROUND Glioblastoma multiforme (GBM) is the most malignant primary brain cancer. Several mutations and alterations of key cellular pathways including tyrosine kinases (TKs) are involved in GBM etiopathogenesis. Currently there is no cure for GBM. Tumour heterogeneity and the presence of the blood brain barrier (BBB), with efflux transporters, are some of the causes of failure of novel therapeutic agents. Thus, appropriate target selectivity and pharmacokinetics (including brain penetration) are critical issues for the generation of potential drug candidates. The main in-vitro and in-vivo properties and antitumour activity of CR13626, a novel brain penetrant TK inhibitor, are presented. MATERIAL AND METHODS CR13626 inhibitory activity against a panel of 173 kinases was assessed. The effect on cellular proliferation was verified in different 2D human glioblastoma cell lines (U87MG, U373, U87MG vIII) and in a U87MG 3D spheroid model by ViaCount assays. The in-vivo antitumour activity was determined in a mouse model of glioblastoma based on the orthotopic injection of U87MG-Luciferase GBM cells in nude mice: oral treatment started on day 9 post-implantation and continued for 10 days (50 mg/kg/daily). Tumour progression was evaluated through the measurement of bioluminescence (BLI) at the end of dosing (day 19) and during follow-up (day 26–33). Survival was also monitored. The pharmacokinetics and brain exposure of CR13626 were assessed by LC/MS/MS in plasma and brain homogenate tissues of CD1 and tumour-bearing nude mice. RESULTS CR13626 potently inhibited FYN, YES, KDR and EGFR kinases, relevant for GBM development, with IC50 values of 69 nM, 3.6 nM, 82 nM and 6 nM, respectively. The compound reduced the proliferation of different human glioblastoma cell lines (GI50 1–3 µM). In CD1 mice, CR13626 had a good oral bioavailability (72%) and brain penetration (brain/plasma ratio of 1.4). In-vivo BLI analysis indicated a time-dependent reduction of tumour growth, reaching 60% on the last BLI evaluation 33 days post-implantation (i.e. 15 days after the end of dosing). Tumour growth inhibition translated into an increase of 25% of the median survival time of animals treated with CR13626 compared to the vehicle group (p<0.05). The observed antitumour effects agreed with the exposure of tumour-bearing mice to CR13626, which was above the TKs in-vitro IC50 values. CONCLUSION The combined abilities of CR13626 to inhibit the activity of TKs involved in GBM development, to cross the BBB, and to reduce tumour growth in-vivo leading to increased survival, warrant its further development as a drug candidate in GBM.
Styles APA, Harvard, Vancouver, ISO, etc.
2

Khatab, Yacoub, Sayed Reshad Ghafouri, Haider Alkhateeb, Debabrata Mukherjee, Hernando Garcia et Nils Patrick Nickel. « The Association of N-Terminal Pro-Brain Natriuretic Peptide With Time to Clinical Worsening in Hispanic Patients With Pulmonary Arterial Hypertension ». Cardiology Research 13, no 2 (avril 2022) : 73–80. http://dx.doi.org/10.14740/cr1362.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Chaulin, Aleksey Michailovich, et Artem Konstantinovich Sergeev. « The Role of Fine Particles (PM 2.5) in the Genesis of Atherosclerosis and Myocardial Damage : Emphasis on Clinical and Epidemiological Data, and Pathophysiological Mechanisms ». Cardiology Research 13, no 5 (octobre 2022) : 268–82. http://dx.doi.org/10.14740/cr1366.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Doctor, Pezad, William A. Scott, Kaitlin Tindel et Hoang H. Nguyen. « Ivabradine Overdose in a Newborn : Precautions of Dispensing in Infants ». Cardiology Research 13, no 4 (août 2022) : 242–45. http://dx.doi.org/10.14740/cr1392.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Livesay, James, Benjamin Fogelson, Hassan Tahir et Raj Baljepally. « Comparison of Tricuspid Regurgitation Severity Between Cardiac Resynchronization Therapy Versus Right Ventricular Pacing in Patients With Chronic Obstructive Pulmonary Disease ». Cardiology Research 13, no 3 (juin 2022) : 128–34. http://dx.doi.org/10.14740/cr1365.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Safonova, Julia, Maria Kozhevnikova, Yulia Danilogorskaya, Elena Zheleznykh, Vita Zektser, Irina Ilgisonis, Lyudmila Popova, Natalia Khabarova, Elena Privalova et Yuri Belenkov. « Angiotensin-Converting Enzyme Inhibitor Therapy Effects in Patients With Heart Failure With Preserved and Mid-Range Ejection Fraction ». Cardiology Research 12, no 6 (décembre 2021) : 363–68. http://dx.doi.org/10.14740/cr1322.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Abney, Lon, Tyler Coombes, Laylan Shali, Jared Spoons et W. Jeremy Mahlow. « Rate of Recovery of Left Ventricular Ejection Fraction in a Real-World Population of Patients Receiving a Wearable Cardioverter Defibrillator ». Cardiology Research 12, no 6 (décembre 2021) : 340–43. http://dx.doi.org/10.14740/cr1325.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Ahmad, Hoda Abdolmonem, Dixon Thomas, Maryam Alrais, Aaron Burton et Rajaram Jagdale. « Shortcoming of Measuring Patient Satisfaction’s Association With Anemia-Based Cardiovascular Risk in End-Stage Kidney Disease Patients ». Cardiology Research 12, no 6 (décembre 2021) : 344–50. http://dx.doi.org/10.14740/cr1332.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Schloss, Brian, Ismail Bekiroglu, Colin O’Connor, Simon Lee, Julie Rice, Stephani S. Kim et Joseph D. Tobias. « Hemodynamic and Respiratory Effects of Regadenoson During Radiologic Imaging in Infants and Children ». Cardiology Research 12, no 6 (décembre 2021) : 329–34. http://dx.doi.org/10.14740/cr1323.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Arshad, Samiullah, George A. Davis, Muhammad Amir, Ythan H. Goldberg, Vedant A. Gupta, Ahmed K. Abdel-Latif et Susan Smyth. « Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center ». Cardiology Research 13, no 2 (avril 2022) : 88–96. http://dx.doi.org/10.14740/cr1352.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
11

Thakker, Ravi A., Rafic F. Berbarie, Paul Kumfa et Syed Gilani. « Snaring Technique for Removal of Entrapped Coronary Guidewire in the Left Anterior Descending Artery ». Cardiology Research 13, no 2 (avril 2022) : 118–21. http://dx.doi.org/10.14740/cr1369.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
12

Kewcharoen, Jakrin, Andrew K. Chang, Purvi Parwani, Gary Fraser, Aditya Bharadwaj, Ahmed Seliem, Diane Tran, Liset Stoletniy, Antoine Sakr et Dmitry Abramov. « Echocardiographic Parameters and Outcomes in Methamphetamine-Associated Heart Failure : A Propensity Score-Weighted Analysis ». Cardiology Research 13, no 2 (avril 2022) : 81–87. http://dx.doi.org/10.14740/cr1364.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
13

Papadis, Athanasios, Stefano Svab, Nicolas Brugger, Jonas Lanz, Robert von Arx, Konstantinos Stamou et Stefanos Sakellaropoulos. « “Broken Heart” and “Broken Brain” : Which Connection ? » Cardiology Research 13, no 1 (février 2022) : 65–70. http://dx.doi.org/10.14740/cr1336.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
14

Munlemvo, Dolly M., Joseph D. Tobias, Kristin M. Chenault et Aymen Naguib. « Prothrombin Complex Concentrates to Treat Coagulation Disturbances : An Overview With a Focus on Use in Infants and Children ». Cardiology Research 13, no 1 (février 2022) : 18–26. http://dx.doi.org/10.14740/cr1342.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
15

Somberg, John. « Heart Failure Research and Polypharmacy ». Cardiology Research 13, no 1 (février 2022) : 1. http://dx.doi.org/10.14740/cr1356.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
16

Saitoh, Masakazu, Tetsuya Takahashi, Tomoyuki Morisawa, Akio Honzawa, Miho Yokoyama, Abidan Abulimiti, Nobuyuki Kagiyama et al. « Remote Cardiac Rehabilitation in Older Cardiac Disease : A Randomized Case Series Feasibility Study ». Cardiology Research 13, no 1 (février 2022) : 57–64. http://dx.doi.org/10.14740/cr1346.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
17

Nik Mohamed Kamal, Nik Mohamed Firdaus, Nasibah Mohamad et Bazli Md Yusoff. « Dizziness and syncope after subclavian steal : A case report of a rarely symptomatic, common vascular disorder ». Malaysian Family Physician 17, no 1 (15 mars 2022) : 82–85. http://dx.doi.org/10.51866/cr1306.

Texte intégral
Résumé :
Subclavian steal syndrome (SSS) is a manifestation of vertebrobasilar artery insufficiency due to stenosis of the proximal subclavian artery. It is a common vascular disorder; however, most patients are asymptomatic, and the disorder is commonly found incidentally during imaging. Nevertheless, some patients may present with arm ischemia or signs and symptoms of vertebrobasilar insufficiency, such as vertigo, dizziness, diplopia, ataxia, dysarthria, and syncopal episodes. We present a case of a male patient who presented with sudden onset dizziness, syncopal episodes, and blood pressure discrepancy between his arms. Diagnosis was a challenge, and the patient underwent several investigations, including basic bloodwork, electrocardiography (ECG), echocardiography, brain computed tomography (CT), and coronary CT angiography (CTA). Narrowing in the proximal left subclavian artery was found during coronary CTA, which confirmed the diagnosis of SSS.
Styles APA, Harvard, Vancouver, ISO, etc.
18

Takara, Yuki, Masakazu Saitoh, Tomoyuki Morisawa, Tetsuya Takahashi, Nozomu Yoshida, Munetoshi Sakiyama, Ryuta Nakamura, Imun Tei et Toshiyuki Fujiwara. « Clinical Characteristics of Older Heart Failure Patients With Hospital-Acquired Disability : A Preliminary, Single-Center, Observational Study ». Cardiology Research 12, no 5 (octobre 2021) : 293–301. http://dx.doi.org/10.14740/cr1306.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
19

Somberg, John. « Do We Serve a Need ? » Cardiology Research 12, no 5 (octobre 2021) : 269. http://dx.doi.org/10.14740/cr1324.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
20

Wong, Rebecca Pei Ying, et Philip George. « Covid-19, not your normal flu : A case report on Covid-19 psychosis and mania in a Malaysian hospital ». Malaysian Family Physician 17, no 3 (2 août 2022) : 144–48. http://dx.doi.org/10.51866/cr1369.

Texte intégral
Résumé :
Evidence suggests that acute severe coronavirus disease 2019 (COVID-19) may be associated with neuropsychiatric symptoms. This is a case report of a patient who had recently been infected with COVID-19 and had no history of psychiatric disorders presenting a few days after inpatient discharge from COVID-19 treatment with acute onset of psychosis and manic symptoms. This case illustrates the psychiatric presentation, possible causes, and management of post-COVID-19 psychosis.
Styles APA, Harvard, Vancouver, ISO, etc.
21

May, André, Ronaldo Da Silva Viana, Michelli De Souza Dos Santos et Evandro Henrique Figueiredo Moura Da Silva. « Aplicação de glyphosate na dessecação do sorgo biomassa ». Revista Brasileira de Herbicidas 15, no 4 (10 décembre 2016) : 362. http://dx.doi.org/10.7824/rbh.v15i4.487.

Texte intégral
Résumé :
O sorgo biomassa é uma alternativa para a geração de energia renovável pela queima em caldeiras, destacando-se por sua alta produtividade e possibilidade de mecanização de todos os seus processos agrícolas. Uma alternativa comum para a redução da umidade de culturas é a aplicação de herbicidas dessecantes, contudo, não há pesquisas que elucidem a perda de umidade da massa colhida de sorgo com a aplicação de dessecantes na parte aérea, antes da colheita. Assim, o objetivo deste trabalho foi avaliar aplicação de glyphosate na dessecação do sorgo. O delineamento experimental utilizado foi em blocos inteiramente casualizados, no esquema fatorial 2x5x4, constituídos por: duas cultivares de sorgo (BRS 716 e CR 1342); cinco doses de glyphosate (0, 720, 1.440, 2.160 e 2.880 g ingrediente ativo ha-1) e quatro épocas de coleta das plantas (7, 14, 21 e 28 dias após a aplicação), com 4 repetições. Durante as diferentes épocas de coleta das plantas foram realizadas as avaliações da biomassa fresca e seca dos colmos e folhas e porcentagem de biomassa seca dos colmos e das folhas. A aplicação do glyphosate não foi eficaz no processo de dessecação das plantas de sorgo biomassa BRS 716 e CR1342.
Styles APA, Harvard, Vancouver, ISO, etc.
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!

Vers la bibliographie